A number of molecules are involved in the modulation of mTOR signaling, and specific inhibitors show a good performance in prevention and treatment of various tumors including oral cancer, ovarian cancer, and lung carcinoma [57–59]. This evidence concerns the gene MTOR and ovarian cancer.